期刊文献+

流感病毒神经氨酸酶抑制剂的合成筛选 被引量:3

Screening and synthesis of influenza neuraminidase inhibitors
下载PDF
导出
摘要 总结流感神经氨酸酶抑制剂有效的结构特点及其结晶结构 ,对神经氨酸酶抑制剂进行了合成探索和构效关系研究 ,共设计合成 6个未见报道的新化合物 ,其中 3个为目标物 ,3个为中间体 ,通过MS ,1 H NMR证明其结构 ,并测定了它们的抑酶活性 ,结果所有化合物对神经氨酸酶都显示一定活性。同时还测定了这几个化合物抗流感病毒株粤防 72 2 4 3的活性及体外抗HIV 1整合酶活性。 On the basis of effective structural feature and crystal structure of the neuraminidase inhibitors, some research on the synthesis and structure activity relationship of neuraminidase inhibitors was conducted. Six new compounds have been prepared in the study, including three intermediates and three target compounds. All compounds synthesized were verified by 1 H NMR and MS. They all had some effects against neuraminidase, and the activity against virus YueFang 72 243 in vitro was also studied.
机构地区 中国医学科学院
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2002年第9期529-531,556,共4页 Chinese Journal of Antibiotics
关键词 神经氨酸酶 合成 流感 构效关系 流感病毒神经氨酸酶抑制剂 Neuraminidase Synthesis Inhibitor
  • 相关文献

参考文献5

  • 1Stamboulian D, Bonvehi P E, Nacinovich F M, et al. Influenza[J]. Infect Dis Clin North Am ,2000; 14(1): 141
  • 2Woodhead M, Lavanchy D, Johnstons S, et al. Neuraminidase inhibitors: progress in the management of influenza [J]. 2000;54(9):604
  • 3Kim C U, Chen X, Mendel D B, et al. Neuraminidase inhibitors as anti-influenza virus agents [J]. Antivir Chem Chemother, 1999;10(4): 141
  • 4Babu Yarlagadda S, Montgomery John A, Chand P, et al. Substituted cyclopentane compounds useful as neuraminidase inhibitors[J]. WO 97 47194,1977-12-18
  • 5王葆仁.金属有机物还原[A].金属有机合成反应(上册)[M].北京:科学出版社,1981:138

同被引文献33

  • 1Service R F. Researchers seek new weapon against the flu [J]. Science, 1997,275(5301):756-757.
  • 2Pinto L H, Holsinger L, Lamb R A. Influenza virus M2 protein has ion channel activity [J]. Cell, 1992, 69(3):517-528.
  • 3Kimberlin D W, Coen D M, Biron K K, et al. Molecular mechanisms of antiviral resistance [J]. Antiviral Res, 1995, 26(4):369-401.
  • 4von Itzstein M, Wu W Y, Kok G B, et al. Rational design of potent sialidase-based inhibitors of influenza virus replication [J]. Nature, 1993, 363(6428):418-423.
  • 5Dunn C J, Goa K L, Zanamivir:a review of its use in influenza [J]. Drugs, 1999,58:761.
  • 6von Itzstein M, Dyason J C, Oliver S W, et al. A study of the active site of influenza virus sialidase:an approach to the rational design of novel anti-influenza drugs [J]. J Med Chem, 1996,39:388-391.
  • 7Fromtling R A. Zanamivir [J]. Drugs Fut, 2000, 25(4):430-433.
  • 8Singh S, Jedrzejas M J, Air G M, et al. Structure-based inhibitors of influenza virus sialidase.A benzoic acid lead with novel interaction [J]. J Med Chem, 1995,38:3217-3225.
  • 9Chand P, Babu Y S, Bantia S, et al. Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-baced drug design [J]. J Med Chem, 1997, 40:4030-4052.
  • 10Atigadda V R, Brouillette W J, Duarte F, et al. Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidione substituent [J]. J Med Chem, 1999, 42:2332-2343.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部